The Vaishali Pharma IPO date has been confirmed to have started on August 7, 2017 and ended on August 10, 2017.
Using an IPO, Vaishali Pharma is seeking to raise Rs 14.23 crore. Its price band is set at ₹71 to ₹72 per share. The minimum lot size for an application is 1600 shares. The minimum amount of investment required by retail investors is ₹115,200.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
August 7-10
Price Range
₹71 to ₹72 per share
Face Value
₹10 per share
GMP
₹142.25
Vaishali Pharma IPO GMP
The Vaishali Pharma Limited IPO GMP is ₹142.25.
IPO Overview
The Vaishali Pharma IPO is a Rs 14.23 crore book-built issuance. Bidding for the Vaishali Pharma IPO began on August 7, 2017 and finished on August 10, 2017. On August 22, 2017, the shares were listed on the NSE SME. The IPO price band for Vaishali Pharma is established at 71 to 72 per share. An application requires a minimum lot size of 1600 shares. Retail investors are obliged to make a minimum investment of 115,200.
They export Formulations, Surgical, and APIs to Kenya, Sri Lanka, Russia, the Democratic Republic of the Congo, Myanmar, Tajikistan, Bangladesh, Kazakhstan, Cameroon, Jordan, Burkina Faso, Nicaragua, Senegal, Pakistan, Ukraine, Yemen, Cambodia, Turkey, Congo, Zimbabwe, Ethiopia, Tanzania, Vietnam, Armenia, Costa Rica, Nigeria, the Central African Republic, and Guinea-Bissau.
Vaishali Pharma IPO Details
| IPO Date | August 7, 2017 to August 10, 2017 |
| Listing Date | August 22, 2017 |
| Face Value | ₹10 per share |
| Price Band | ₹71 to ₹72 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 1,976,000 shares (aggregating up to ₹14.23 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
Vaishali Pharma Company Financials
| Particulars | For the year or period ended (in Rs. Lakhs) | |||||
|---|---|---|---|---|---|---|
| 31-Mar-17 | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | ||
| Total Assets | 4464.87 | 4941.31 | 4579.50 | 5342.97 | 4858.17 | |
| Total Revenue | 6711.22 | 6989.13 | 9882.37 | 12156.90 | 11909.85 | |
| Profit After Tax | 66.37 | (3.03) | 16.15 | 30.05 | 60.00 | |
Vaishali Pharma IPO Listing Details
| Listing Date | August 22, 2017 |
| BSE Script Code | |
| NSE Symbol | VAISHALI |
| ISIN | INE972X01014 |
| Final Issue Price | ₹72 per share |
Company Profile
Vaishali Pharma Ltd, founded in 2008, is a pharmaceutical firm that specialises in pharmaceutical formulations, APIs, surgical goods, veterinary supplements, and herbal and nutraceutical products. They operate in both domestic and international markets. They have also opened an office in Vietnam. They currently supply roughly ten countries. They primarily trade APIs in domestic markets, while they trade and market APIs, formulations, surgical items, and other products in export markets. They recently applied for 186 product registrations in 13 countries and gained 71 approvals from 7 nations.
Registrar Info
| Name | Bigshare Services Pvt Ltd |
| Phone number | +91-22-6263 8200 |
| Email ID | ipo@bigshareonline.com |
| Website | ipo.bigshareonline.com |
Contact Details
| Name | Vaishali Pharma Ltd |
| Phone number | + 91-22-28928833 |
| Email ID | investor@vaishalipharma.com |
| Website | vaishalipharma.com |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
